RDEA3170 AME Study

NCT01910506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RDEA3170 10 mg

Sponsor

Ardea Biosciences, Inc.